Does ALOGLIPTIN\METFORMIN Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with ALOGLIPTIN\METFORMIN. This represents 1.6% of all adverse event reports for ALOGLIPTIN\METFORMIN.
6
Reports of Interstitial lung disease with ALOGLIPTIN\METFORMIN
1.6%
of all ALOGLIPTIN\METFORMIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Interstitial lung disease From ALOGLIPTIN\METFORMIN?
Of the 6 reports, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN\METFORMIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ALOGLIPTIN\METFORMIN Cause?
Off label use (35)
Diarrhoea (34)
Pneumonia (24)
Pemphigoid (19)
Disease recurrence (18)
Drug ineffective (17)
Hypertension (17)
Lactic acidosis (17)
Tonsil cancer (16)
Blood pressure increased (15)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ALOGLIPTIN\METFORMIN Alternatives Have Lower Interstitial lung disease Risk?
ALOGLIPTIN\METFORMIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN\METFORMIN vs ALOSETRON
ALOGLIPTIN\METFORMIN vs ALPELISIB
ALOGLIPTIN\METFORMIN vs ALPHA.-LIPOIC ACID
ALOGLIPTIN\METFORMIN vs ALPHA.-TOCOPHEROL